174 related articles for article (PubMed ID: 14694766)
1. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
Weiss T
Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
Thum J; Caspary L; Creutzig A; Alexander K
Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
4. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
Sinzinger H; Rogatti W
Wien Klin Wochenschr; 1991; 103(18):558-65. PubMed ID: 1750223
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
Weiss T; Eckstein H; Weiss C; Diehm C
Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacologic concepts for clinical use of prostaglandin E1].
Schrör K
Vasa Suppl; 1991; 33():335-6. PubMed ID: 1788746
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease.
Schrör K; Hohlfeld T
Vasa; 2004 Aug; 33(3):119-24. PubMed ID: 15461062
[TBL] [Abstract][Full Text] [Related]
8. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
9. Hemostatic and fibrinolytic effects of systemic prostaglandin E1 therapy in patients with peripheral arterial disease.
Kuss M; Heidrich H; Koettgen E
Vasa; 2003 Aug; 32(3):145-8. PubMed ID: 14524034
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
11. Skin oxygen pressure histograms in patients with peripheral arterial occlusive disease during intraarterial and intravenous prostaglandin E1 infusions of different dosages and their prognostic value.
Creutzig A; Arnold A; Caspary L; Thum J; Alexander K
Angiology; 1995 May; 46(5):357-67. PubMed ID: 7741319
[TBL] [Abstract][Full Text] [Related]
12. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Hesse WH; Rudofsky G; Peskar BA
Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
[TBL] [Abstract][Full Text] [Related]
14. Endothelial function in patients with peripheral vascular disease: influence of prostaglandin E1.
Weiss T; Fischer D; Hausmann D; Weiss C
Prostaglandins Leukot Essent Fatty Acids; 2002 Nov; 67(5):277-81. PubMed ID: 12445486
[TBL] [Abstract][Full Text] [Related]
15. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.
Böger RH; Bode-Böger SM; Thiele W; Creutzig A; Alexander K; Frölich JC
J Am Coll Cardiol; 1998 Nov; 32(5):1336-44. PubMed ID: 9809945
[TBL] [Abstract][Full Text] [Related]
16. [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
Neumann FJ; Diehm C; Müller-Bühl U; Weiss T; Zimmermann R; Tillmanns H; Kübler W
Vasa Suppl; 1989; 27():40-1. PubMed ID: 2623539
[No Abstract] [Full Text] [Related]
17. Recanalization of chronic peripheral arterial occlusions by alternating intra-arterial rt-PA and PGE1.
Kröger K; Hwang I; Rudofsky G
Vasa; 1998 Feb; 27(1):20-3. PubMed ID: 9540428
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
19. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.
Weiss C; Regele S; Velich T; Bärtsch P; Weiss T
Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):271-7. PubMed ID: 11090253
[TBL] [Abstract][Full Text] [Related]
20. Iontophoretic administration of prostaglandin E1 in peripheral arterial occlusive disease.
Sakurai T; Yamamura K
Ann Pharmacother; 2003 May; 37(5):747. PubMed ID: 12708957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
